Cargando…

Therapeutic Strategies for Targeting IL-1 in Cancer

SIMPLE SUMMARY: Interleukin-1 cytokines are key proinflammatory cytokines which have been implicated with differing pro- and antitumorigenic properties. Recent years have brought exciting insights and developments in IL-1-targeted therapies. Here, we present an overview of past and present research...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gottschlich, Adrian, Endres, Stefan, Kobold, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865618/ https://www.ncbi.nlm.nih.gov/pubmed/33530653 http://dx.doi.org/10.3390/cancers13030477

Ejemplares similares

CAR T cell therapy in solid tumors: a short review
por: Umut, Öykü, et al.
Publicado: (2021)

Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment
por: Huynh, Duc, et al.
Publicado: (2022)

Migratory Engineering of T Cells for Cancer Therapy
por: Michaelides, Stefanos, et al.
Publicado: (2022)

The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma model
por: Kobold, Sebastian, et al.
Publicado: (2013)

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
por: Stoiber, Stefan, et al.
Publicado: (2019)

Enhanced Chimeric Antigen Receptor T Cell Therapy through Co-Application of Synergistic Combination Partners
por: Stock, Sophia, et al.
Publicado: (2022)

Interleukins in cancer: from biology to therapy
por: Briukhovetska, Daria, et al.
Publicado: (2021)

IL-1RAP, a Key Therapeutic Target in Cancer
por: Frenay, Jame, et al.
Publicado: (2022)

The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors
por: Kolorz, Julian, et al.
Publicado: (2021)

Teaching an old dog new tricks: next-generation CAR T cells
por: Tokarew, Nicholas, et al.
Publicado: (2018)

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2019)

PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models
por: Lesch, Stefanie, et al.
Publicado: (2022)

Therapeutic potential of targeting IL-17 and IL-23 in sepsis
por: Bosmann, Markus, et al.
Publicado: (2012)

Targeting KRAS in Cancer: Promising Therapeutic Strategies
por: Mustachio, Lisa Maria, et al.
Publicado: (2021)

IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting
por: Broderick, Lori, et al.
Publicado: (2022)

Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy
por: Dong, Haonan, et al.
Publicado: (2022)

Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
por: Muhammad, Shan, et al.
Publicado: (2023)

Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
por: Heo, Tae-Hwe, et al.
Publicado: (2016)

Type I IL-1 Receptor (IL-1RI) as Potential New Therapeutic Target for Bronchial Asthma
por: Lee, Jyh-Hong, et al.
Publicado: (2010)

Therapeutic strategies targeting cancer stem cells
por: Yoshida, Go J., et al.
Publicado: (2015)

Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
por: Yang, Wookyeom, et al.
Publicado: (2021)

Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer
por: Masucci, Maria Teresa, et al.
Publicado: (2022)

Evolving role of cetuximab in the treatment of colorectal cancer
por: Schuch, Gunter, et al.
Publicado: (2009)

Mesenchymal stem cells overexpressing IL-35: a novel immunosuppressive strategy and therapeutic target for inducing transplant tolerance
por: Guo, Hao, et al.
Publicado: (2018)

Chimeric Antigen Receptor–Modified T Cells and T Cell–Engaging Bispecific Antibodies: Different Tools for the Same Job
por: Schwerdtfeger, Melanie, et al.
Publicado: (2021)

Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinoma
por: Duewell, Peter, et al.
Publicado: (2015)

Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies
por: Sánchez-Rodríguez, Guillermo, et al.
Publicado: (2023)

Therapeutic Strategies Targeting Tumor Suppressor Genes in Pancreatic Cancer
por: Kuo, Kung-Kai, et al.
Publicado: (2021)

Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies
por: Farkhondeh, Tahereh, et al.
Publicado: (2021)

Novel therapeutic Strategies for Targeting Liver Cancer Stem Cells
por: Oishi, Naoki, et al.
Publicado: (2011)

Therapeutic Targeting Strategies of Cancer Stem Cells in Gastrointestinal Malignancies
por: Sonbol, Mohamad B., et al.
Publicado: (2019)

Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies
por: Reynolds, Carson R., et al.
Publicado: (2022)

Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment
por: Janneh, Alhaji H., et al.
Publicado: (2022)

Targeting autophagy as a therapeutic strategy against pancreatic cancer
por: Yamamoto, Keisuke, et al.
Publicado: (2022)

Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies
por: Nadhan, Revathy, et al.
Publicado: (2023)

IL-20 bone diseases involvement and therapeutic target potential
por: Wang, Hsiao-Hsuan, et al.
Publicado: (2018)

PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma
por: Rataj, Felicitas, et al.
Publicado: (2018)

Targeted Pyroptosis Is a Potential Therapeutic Strategy for Cancer
por: Wu, Hao, et al.
Publicado: (2022)

Targeting glutamine metabolism as a therapeutic strategy for cancer
por: Jin, Jonghwa, et al.
Publicado: (2023)

Nano‐therapeutic strategies to target coronavirus
por: Rauf, Mohd Ahmar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hj6gdftvrffktl42nm7f0pv3fd